Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2021-11-19 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and capital changes, not a full financial report or earnings release. It is a regulatory disclosure about share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length is over 10,000 characters and contains detailed transactional data, confirming it is not a brief announcement or certification but a substantive report on share repurchases.
2021-11-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and disclosures required by the exchange rules. It is not a full financial report, earnings release, or management discussion. It is a regulatory disclosure about share repurchases and capital changes. This fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2021-11-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares, dates, quantities, prices, and confirmations that these transactions comply with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase activity and capital changes, not on financial results, management commentary, or regulatory certifications. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 10,000 characters and contains detailed transactional data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is 'POS' (Transaction in Own Shares).
2021-11-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and changes in capital structure rather than financial results, management changes, or regulatory filings unrelated to capital. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is POS with high confidence.
2021-11-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and capital changes rather than financial results, management changes, or regulatory certifications. The document is about share buybacks and changes in issued share capital, which aligns with the category for announcements regarding share repurchases or capital changes. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a substantive disclosure of share transactions.
2021-11-15 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed information on repurchases of shares, dates, prices, and confirmations that these repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length and content confirm it is not merely an announcement but a detailed disclosure form.
2021-11-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.